SiriusPoint Completes Strategic Divestment of Arcadian Stake
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An update from SiriusPoint ( (SPNT) ) is now available.
On January 30, 2026, a SiriusPoint Ltd. subsidiary completed the previously announced sale of its entire equity stake in Arcadian Holdings Limited, a Bermuda exempted company, to Comet Bidco Limited, an acquisition vehicle affiliated with Lee Equity Partners. Under the terms of the October 3, 2025 share purchase agreement, SiriusPoint’s Bermuda insurance unit received $140 million in cash consideration, subject to customary post-closing adjustments, with the deal closing after satisfaction of regulatory and other standard conditions, marking a strategic divestment that monetizes a non-core holding and potentially strengthens SiriusPoint’s capital position.
The most recent analyst rating on (SPNT) stock is a Buy with a $22.50 price target. To see the full list of analyst forecasts on SiriusPoint stock, see the SPNT Stock Forecast page.
Spark’s Take on SPNT Stock
According to Spark, TipRanks’ AI Analyst, SPNT is a Outperform.
SiriusPoint’s strong financial performance and positive earnings call are the most significant factors driving the score. The company’s robust cash flow and strategic disposals enhance its financial position. Technical indicators suggest caution due to potential overbought conditions, but the overall outlook remains positive.
To see Spark’s full report on SPNT stock, click here.
More about SiriusPoint
SiriusPoint Ltd. operates in the insurance and reinsurance industry through subsidiaries such as SiriusPoint Bermuda Insurance Company Ltd., providing risk transfer and related insurance solutions to global clients from its Bermuda base.
Average Trading Volume: 639,157
Technical Sentiment Signal: Buy
Current Market Cap: $2.35B
Learn more about SPNT stock on TipRanks’ Stock Analysis page.
